SIVEXTRO: payments to doctors
Payments that named SIVEXTRO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $603K
- Providers
- 11,729
- Transactions
- 22,841
- Average per transaction
- $26
The per-transaction average — $26 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 11,729 providers the average total is $51, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Merck | $501,076 | 83.1% |
| Nabriva Therapeutics, PLC | $81,486 | 13.5% |
| Comsort, Inc | $20,600 | 3.4% |